MURA: Mural Oncology plc Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 41.69
Enterprise Value ($M) -102.69
Book Value ($M) 140.50
Book Value / Share 8.16
Price / Book 0.30
NCAV ($M) 124.03
NCAV / Share 7.20
Price / NCAV 0.34

Profitability (mra)
Return on Invested Capital (ROIC) -0.85
Return on Assets (ROA) -0.49
Return on Equity (ROE) -0.55

Liquidity (mrq)
Quick Ratio 5.34
Current Ratio 5.34

Balance Sheet (mrq) ($M)
Current Assets 152.93
Assets 169.39
Liabilities 28.89
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -138.26
Net Income -128.51

Cash Flow Statement (mra) ($M)
Cash From Operations -128.54
Cash from Investing -25.33
Cash from Financing 0.20

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
3 days ago 13G Soleus Capital Master Fund, L.P. 6.30
02-14 13G/A Armistice Capital, Llc 9.96 0.00
02-14 13G/A Acorn Bioventures, L.p. 7.60
11-14 13G Solas Capital Management, LLC 7.40
11-12 13G/A Vanguard Group Inc 4.90 0.00
08-05 13G/A Westfield Capital Management Co Lp 0.00 -100.00
07-08 13G/A BlackRock, Inc. 2.00 -70.79

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 1,515,998 5,210,033 29.10
2025-04-16 1,447,272 6,501,855 22.26
2025-04-15 79,781,295 207,512,346 38.45
2025-04-14 67,845 215,019 31.55

(click for more detail)

Similar Companies
MNKD – MannKind Corporation MNOV – MediciNova, Inc.
MRUS – Merus N.V. NAII – Natural Alternatives International, Inc.
NAMS – NewAmsterdam Pharma Company N.V.


Financial data and stock pages provided by
Fintel.io